Intraspinal degenerative atrophy caused by sciatic nerve lesions prevented by acetyl-L-carnitine.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  International journal of clinical pharmacology research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1284500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.

  1992cited by this paper
• Effect of acetyl‐L‐carnitine on the dopaminergic system in aging brain

  1991cited by this paper
• Reversibility and prevention of intraspinal peptidergic loss caused by sciatic nerve lesions

  1989cited by this paper
• Spinal cord interneuron degenerative atrophy caused by peripheral nerve lesions is prevented by serotonin depletion

  1987cited by this paper
• Peripheral nerve lesions cause simultaneous alterations of substance P and enkephalin levels in the spinal cord.

  1985cited by this paper
• Structural and biochemical alterations in the dorsal horn of the spinal cord caused by peripheral nerve lesions.

  1985cited by this paper
• Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.

  1984cited by this paper
• An immunohistochemical study of neuronal populations containing neuropeptides or gamma-aminobutyrate within the superficial layers of the rat dorsal horn.

  1981cited by this paper
• Substance P: depletion in the dorsal horn of rat spinal cord after section of the peripheral processes of primary sensory neurons.

  1979cited by this paper
• Reorganisation of spinal cord sensory map after peripheral nerve injury

  1978cited by this paper

• Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond

  2013cites this paper
• Prevention of Postischemic Spinal Cord Injury by Means of Regional Infusion of Adenosine and L-carnitine Dissolved in Normothermic Saline

  2004cites this paper
• Reduction of glutamate levels in HIV-infected subjects treated with acetylcarnitine.

  1999cites this paper
• Acetyl‐carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues

  1997cites this paper
• Carnitine Today

  1997cites this paper
• L-Carnitine, a Modulator of Immunometabolic Homeostasis in Subjects Infected with the Human Immunodeficiency Virus

  1997cites this paper
• Acetyl-L-carnitine prevents age-dependent structural alterations in rat peripheral nerves and promotes regeneration following sciatic nerve injury in young and senescent rats.

  1994cites this paper
• Impaired Axonal Transport in Diabetic Neuropathy

  1994cites this paper
• PHARMACOLOGICAL TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY: CHALLENGES AND POSSIBILITIES

  1994cites this paper
• Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.

  1992cites this paper